贝因美(002570) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥636,322,586.28, representing a 12.25% increase compared to ¥566,858,555.71 in the same period last year[4] - Net profit attributable to shareholders for Q1 2022 was ¥20,126,374.67, a 38.45% increase from ¥14,537,381.04 year-over-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 266.35% to ¥15,517,744.73 from ¥4,235,790.79 in the previous year[4] - Total operating revenue for Q1 2022 was CNY 636,322,586.28, an increase of 12.24% compared to CNY 566,858,555.71 in Q1 2021[24] - Net profit for Q1 2022 reached CNY 20,984,457.67, compared to CNY 18,810,095.29 in Q1 2021, representing an increase of 11.59%[25] Cash Flow - The net cash flow from operating activities increased by 145.02% to ¥52,895,828.43, up from ¥21,588,202.87 in the same quarter last year[4] - The cash inflow from operating activities totaled CNY 709,547,323.73, compared to CNY 631,773,462.88 in Q1 2021, reflecting an increase of 12.34%[27] - The net cash flow from investment activities was -55,799,467.44 CNY, compared to -35,130,372.28 CNY in the previous year, indicating a significant increase in cash outflow[28] - Cash inflow from financing activities totaled 456,813,283.34 CNY, down from 632,522,663.54 CNY year-over-year[28] - The net cash flow from financing activities was -31,319,485.85 CNY, contrasting with a slight positive net flow of 716,698.53 CNY in the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,112,136,081.48, a 1.05% increase from ¥4,069,421,166.85 at the end of the previous year[4] - The total liabilities as of the end of Q1 2022 amounted to CNY 2,257,924,509.83, slightly up from CNY 2,232,686,402.91 at the end of Q1 2021[21] - The company's cash and cash equivalents increased to CNY 762,081,077.77 from CNY 676,870,643.54, reflecting a growth of approximately 12.6%[19] - Inventory decreased significantly from CNY 505,645,822.70 to CNY 395,590,039.67, a reduction of about 21.8%[19] - Short-term borrowings rose to CNY 1,111,156,125.70, up from CNY 1,011,350,119.07, indicating an increase of approximately 9.9%[20] Shareholder Equity - The equity attributable to shareholders increased by 0.93% to ¥1,802,455,204.51 from ¥1,785,836,479.80 at the end of the last year[4] - The total equity attributable to shareholders of the parent company was CNY 1,802,455,204.51, an increase from CNY 1,785,836,479.80 year-over-year[21] - The company repurchased 8,286,307 shares, accounting for 0.77% of the total share capital[16] Operating Expenses - Operating expenses increased by 21.14% to ¥32,000,000, reflecting the rise in revenue[10] - Total operating costs for Q1 2022 were CNY 595,416,761.88, up from CNY 543,555,353.94 in the same period last year, reflecting a growth of 9.55%[24] - Research and development expenses for Q1 2022 were CNY 4,553,454.36, a slight decrease from CNY 4,754,671.25 in Q1 2021[24] Other Financial Metrics - Basic and diluted earnings per share both doubled to ¥0.02 from ¥0.01 year-over-year[4] - The company experienced a 73.56% reduction in financial expenses, decreasing to ¥426,000 from ¥1,611,000 in the previous year[10] - The company reported a decrease in other comprehensive income after tax of CNY -3,842,449.96 compared to CNY -1,396,328.67 in the previous year[25] - The company has established a joint venture, Yibei Intelligent (Hangzhou) Nutrition Technology Co., Ltd., with a registered capital of CNY 10 million, where the company holds a 40% stake[17] Audit Information - The company did not undergo an audit for the first quarter report[29]